Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Total Liabilities: 2018-2025

Historic Total Liabilities for Zai Lab (ZLAB) over the last 7 years, with Sep 2025 value amounting to $399.0 million.

  • Zai Lab's Total Liabilities rose 25.60% to $399.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.0 million, marking a year-over-year increase of 25.60%. This contributed to the annual value of $344.9 million for FY2024, which is 43.58% up from last year.
  • According to the latest figures from Q3 2025, Zai Lab's Total Liabilities is $399.0 million, which was up 7.15% from $372.4 million recorded in Q2 2025.
  • Zai Lab's Total Liabilities' 5-year high stood at $399.0 million during Q3 2025, with a 5-year trough of $121.6 million in Q1 2021.
  • Moreover, its 3-year median value for Total Liabilities was $283.2 million (2024), whereas its average is $277.4 million.
  • As far as peak fluctuations go, Zai Lab's Total Liabilities spiked by 170.12% in 2021, and later dropped by 24.11% in 2022.
  • Over the past 5 years, Zai Lab's Total Liabilities (Quarterly) stood at $230.0 million in 2021, then declined by 24.11% to $174.5 million in 2022, then surged by 37.60% to $240.2 million in 2023, then spiked by 43.58% to $344.9 million in 2024, then climbed by 25.60% to $399.0 million in 2025.
  • Its Total Liabilities stands at $399.0 million for Q3 2025, versus $372.4 million for Q2 2025 and $362.6 million for Q1 2025.